-
Comment on A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR stud
Author: Liang, Jiaqi; Ren, Shuai; Wu, Guangzhen
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. 134, Issue 10, pp. 1367-1368. DOI: 10.1038/s41416-026-03449-3
-
Dynamic reorganisation of intratumoural bacterial florae during colorectal cancer progressio
Author: Li, Minghao; Li, Yang; Li, Chen; Liu, Anhang; Liu, Yang; Xiao, Jian; Zhang, Dongchen; Jin, Yan; Wang, Guangxi; Pang, Xin; Jiang, Kewei; Yin, Yuxin
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. 134, Issue 9, pp. 1261-1275. DOI: 10.1038/s41416-026-03344-x
-
Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells (vol 108, pg 409, 2013
Author: Dixon, K. M.; Lui, G. Y. L.; Kovacevic, Z.; Zhang, D.; Yao, M.; Chen, Z.; Dong, Q.; Assinder, S. J.; Richardson, D. R
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. 134, Issue 7, pp. 1116-1120. DOI: 10.1038/s41416-026-03353-w
-
Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinom
Author: Guo, Wan-Ping; Yu, Xuan; Lu, Zi-Jian; Li, Yu-Chen; Wu, Chun; Gu, Li-Wen; Cao, Jing-Na; Luo, Dong-Hua; Liu, Sai-Lan; Guo, Ling
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41416-026-03401-5
-
TCF3::HLF-positive B-ALL: integrated clinical and molecular characterization of 34 cases from a single-center cohor
Author: Chen, Xue; Ma, Xiaoli; Yuan, Lili; Wang, Fang; Zhang, Yang; Fang, Jiancheng; Cao, Panxiang; Wang, Tong; Xiong, Min; Yang, Junfang; Zhang, Xian; Chen, Jiaqi; Zhou, Xiaosu; Liu, Siyuan; Liu, Hongxing
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41416-026-03370-9
-
Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitor
Author: Huang, Yue; Xi, Yiling; Nie, Huizong; Wang, Yan; Hu, Jiahui; Gao, Yating; Li, Junhui; Ma, Yaofang; Chu, Jiahao; Tu, Linglan; Huang, Dongsheng; Cheng, Liyan
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41416-026-03386-1
-
Furmonertinib combined with bevacizumab in EGFR-TKI-resistant leptomeningeal metastasis: analysis of the CSF ctDNA molecular response and survival outcome
Author: Wang, Xiaoyue; Xie, Yuwen; Hu, Jin; Liu, Na; Yang, Liangfeng; Xu, Ting; Xu, Shu; Yu, Chuanyong; Fang, Shencun
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41416-026-03407-z
-
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT
Author: Chen, Yuli; Chen, Qinnan; Li, Qiuhui; Guo, Jiahao; Li, Ziwei; Li, Hanyang; Hu, Yanming; Guo, Guoqing; Lu, Lu; Li, Qiunuo; Sun, Ming; Liu, Xianghua; Nie, Fengqi
Journal: BRITISH JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1038/s41416-026-03387-0
